神经退行性疾病的特征
David M Wilson1, Mark R Cookson2, Ludo Van Den Bosch3
1Hasselt University, Biomedical Research Institute, BIOMED, 3500 Hasselt, Belgium.
Cell
|February 21, 2023
概括
这项研究概述了神经退行性疾病 (NDD) 的八个主要特征,为了解其机制提供了一个整体框架. 这种方法旨在改善患者分层和个性化疗法,以有效治疗NDD.
科学领域:
- 神经科学
- 遗传学
- 生物化学
背景情况:
- 神经退行性疾病 (NDD) 涉及复杂的遗传和生化途径.
- 现有研究已经确定了许多导致NDD的因素.
研究的目的:
- 提供NDD的八个核心标志的统一框架.
- 建立了解NDD病变,分类和治疗的基础.
主要方法:
- 对NDD的现有研究进行文献审查和综合.
- 八个关键标志及其生物标志物的识别和描述.
主要成果:
- 发现了NDD的八个特征:蛋白质聚合,突触功能障碍,蛋白质平衡失衡,细胞骨问题,能量代谢缺陷,DNA/RNA损伤,炎症和细胞死亡.
- 描述了这些特征之间的相互作用.
- 讨论了每个标志的生物标志物.
结论:
- 一个基于八个特征的整体框架可以推动NDD研究.
- 这一框架支持定义致病机制和分类NDD.
- 它促进了患者分层,并为NDD设计了个性化的多目标疗法.
相关概念视频
Alzheimer's Disease: Overview
591
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
591
Parkinson's Disease: Overview
639
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
639
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
Alzheimer's Disease: Treatment
235
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
235
Amyloid Fibrils
9.7K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.7K
Dementia
151
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
151


